CBG: CBG, or cannabigerol, is a minor cannabinoid that patients may see mentioned in lab reports or extract descriptions.
Included because patients frequently ask about “minor cannabinoids” and encounter product marketing built around them.
Not a routine NHS patient term.
Clinical evidence for specific therapeutic claims is much more limited than commercial language often suggests.